Clinical trial
The Operative Parameters and Postoperative Outcomes of the Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) Technique vs the Traditional HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH): A Randomized Prospective Comparative Study
NCT04391114 is registered in ClinicalTrials.gov with Thunder Bay Regional Health Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Operative Parameters and Postoperative Outcomes of the Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) Technique vs the Traditional HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH): A Randomized Prospective Comparative Study
- Lead sponsor
- Thunder Bay Regional Health Research Institute
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 15, 2019
- Completion date
- December 31, 2026
- Enrollment
- 107 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
benign prostatic hyperplasia, lower urinary tract symptoms